P

Prendio - BioProcure

Biotech eProcurement software with NetSuite integration

Overview

Prendio focuses on biotech procurement by offering a cloud-based eProcurement platform that handles the full procure-to-pay workflow. The software connects with NetSuite, eliminates paper through digital matching, and uses supplier punchouts to streamline purchasing. It is delivered as a subscription service, with custom-built punchouts included at no extra cost, making it easy for biotech teams to manage sourcing, approvals, and invoicing in one system. Unlike more generic procurement tools, Prendio targets biotech firms and integrates tightly with NetSuite to speed up purchasing and reduce time to market. The company’s goal is to help biotech companies run procurement more efficiently so they can focus on research and bringing discoveries to patients more quickly.

Work here?Claim your company

About Prendio - BioProcure

Simplify's Rating
Why Prendio - BioProcure is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Enterprise SoftwareBiotechnology

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Burlington, VT

Founded

2015

Get referred to Prendio - BioProcure

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Larry Birch became CEO in March 2026, sharpening growth execution.
  • Prendio shipped SCIM user provisioning in May 2026, reducing onboarding friction.
  • BIO 2026 presence and CIC, CFGO partnerships expand distribution to early-stage biotechs.

What critics are saying

  • BioProcure depends on biotech funding cycles; customers cut discretionary software spend fast.
  • Prendio's differentiation is narrow; NetSuite, Coupa, and SAP can commoditize procurement workflows.
  • Losing Primus-backed growth momentum or a major customer concentration shock can cripple the business.

What makes Prendio - BioProcure unique

  • Prendio pairs biotech eProcurement software with BioProcure services and supplier marketplace.
  • Primus-backed platform manages billions in life-sciences spend for hundreds of biotechs.
  • SCIM provisioning, NetSuite integration, and custom punchouts fit regulated biotech workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Health Savings Account/Flexible Spending Account
  • Unlimited Paid Time Off
  • Paid Holidays
  • Pet Insurance
  • Legal Services

Company News

Citybiz
Mar 17th, 2026
Prendio and BioProcure appoint larry Birch as Chief Executive Officer.

Prendio and BioProcure appoint larry Birch as Chief Executive Officer. March 17, 2026 Laurence (Larry) Birch Prendio and BioProcure, leading providers of procurement and financial management solutions for the life sciences industry, today announced the appointment of Laurence (Larry) Birch as Chief Executive Officer. Birch will lead the company's next phase of growth as it expands its technology platform and services supporting biotechnology and pharmaceutical companies. Prendio and BioProcure provide a specialized combination of procurement software, financial workflow tools, and supplier network solutions designed specifically for life sciences organizations. Together, the companies offer a unique hybrid of high-touch service and high-tech software that helps research-driven organizations streamline purchasing, improve financial visibility, and operate more efficiently. The platform currently supports hundreds of emerging and mid-stage biotechnology companies across the United States, managing billions of dollars in research and operating spend and helping innovative startups extend their cash runway through strategic supplier relationships. "Biotech companies are operating in an increasingly complex environment where capital efficiency, transparency, and speed are critical," said Birch. "Prendio and BioProcure have built a powerful platform that connects life sciences companies with the tools, suppliers, and financial infrastructure they need to operate effectively. I'm excited to work with the team to expand our capabilities and continue building solutions that help our customers bring new therapies to patients faster." Birch brings decades of leadership experience across life sciences, technology-enabled services, and private equity-backed growth companies. Throughout his career, he has advised and led organizations serving the biotechnology ecosystem, helping scale platforms that support research, development, and commercialization. "Larry brings a unique combination of strategic perspective, industry experience, and leadership," said Phil Molner, Managing Partner of Primus Capital and board member of Prendio. "We are confident he will continue to advance the value Prendio and BioProcure deliver to the life sciences community, helping the life sciences community enhance the quality, speed, and cost effectiveness of their research operations." As CEO, Birch will focus on expanding the company's technology platform, deepening relationships with biotechnology and pharmaceutical customers, and developing new solutions that help life sciences organizations manage purchasing, financial operations, and supplier relationships more effectively. For more than two decades, biotechnology companies have relied on Prendio and BioProcure to modernize procurement and financial operations. By combining specialized software, curated supplier networks, and life sciences expertise, the companies help research-driven organizations simplify purchasing, improve financial control, and accelerate scientific progress. About Prendio Prendio is a cloud-based procure-to-pay platform designed specifically for biotechnology and life sciences organizations. The platform enables companies to manage purchasing, approvals, suppliers, and financial workflows in a streamlined environment tailored to research-driven teams. About BioProcure BioProcure is a group purchasing organization serving the biotechnology industry, helping companies access preferred supplier pricing, simplify procurement and accounts payable processes, and reduce operating costs while accelerating research and development.

PR Newswire
Mar 17th, 2026
Larry Birch named CEO of Prendio and BioProcure, managing billions in life sciences spend

Prendio and BioProcure, procurement and financial management solution providers for life sciences, have appointed Larry Birch as chief executive officer. The companies support hundreds of emerging and mid-stage biotechnology firms across the United States, managing billions of dollars in research and operating spend. Birch brings decades of leadership experience across life sciences, technology-enabled services and private equity-backed growth companies. He will focus on expanding the technology platform, deepening customer relationships and developing new solutions for purchasing and financial operations management. Prendio offers a cloud-based procure-to-pay platform for biotechnology organisations, whilst BioProcure is a group purchasing organisation providing preferred supplier pricing and streamlined procurement processes. Together, they combine procurement software, financial workflow tools and supplier network solutions designed specifically for the life sciences sector.

PR Newswire
Jan 3rd, 2024
BioProcure and Prendio Appoint Eric Meizlish as New CEO

BioProcure and Prendio appoint Eric Meizlish as new CEO.

Yahoo Finance
Oct 18th, 2023
BioProcure and Prendio Announce Strategic Growth Investment From Primus Capital

BioProcure and Prendio announce strategic growth investment from Primus Capital.

ACCESSWIRE
Oct 18th, 2023
BioProcure and Prendio Announce Strategic Growth Investment From Primus Capital

Wednesday, 18 October 2023 12:00

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Prendio - BioProcure right now.

Find jobs on Simplify and start your career today

We update Prendio - BioProcure's jobs every few hours, so check again soon!Browse all jobs